On August 18, 2022 Scandion Oncology (Scandion) reported that it will publish its Q2 2022 interim report on Thursday, August 25, 2022 before 09:00 CET (Press release, Scandion Oncology, AUG 18, 2022, View Source;2022,c3615705 [SID1234618486]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update.

At the end of the presentation there will be a Q&A session.

Access to the event can be obtained as follows:

LIVE access on Thursday August 25, 2022 at 10:00 CET